Cargando…
Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model
The APP[V717I] London (APP-Ld) mouse model recapitulates important pathological and clinical hallmarks of Alzheimer's disease (AD) and is therefore a valuable paradigm for evaluating therapeutic candidates. Historically, both the parenchymal and vascular amyloid deposits, and more recently, tru...
Autores principales: | Tanghe, An, Termont, Annelies, Merchiers, Pascal, Schilling, Stephan, Demuth, Hans-Ulrich, Scrocchi, Louise, Van Leuven, Fred, Griffioen, Gerard, Van Dooren, Tom |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939388/ https://www.ncbi.nlm.nih.gov/pubmed/20862386 http://dx.doi.org/10.4061/2010/417314 |
Ejemplares similares
-
Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice
por: Heneka, Michael T, et al.
Publicado: (2005) -
Effects of tetrahydroxy stilbene glycoside derivatives on free radical damage and apoptosis in APP695V717I transgenic mice
por: Qian, Jun, et al.
Publicado: (2023) -
Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease
por: Lloyd, Grace M., et al.
Publicado: (2020) -
Evaluation of the Hitachi 717 analyser
por: Biosca, Carmen, et al.
Publicado: (1989) -
Phenotypical difference of Amyloid Precursor Protein (APP) V717L mutation in Japanese family
por: Abe, Masao, et al.
Publicado: (2012)